1664-5553

Liver Cancer

S. Karger AG

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 443 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact443 DOIs
2

Add abstracts to 312 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact312 DOIs
3

Deposit reference lists for 312 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact312 DOIs

DOIs for this ISSN

Showing the top 5 of 819 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Treatment of Hepatocellular Carcinoma: A Systematic Review (10.1159/000343828)
Abstract References ORCID License
244.72 279
2 Emerging Signaling Pathways in Hepatocellular Carcinoma (10.1159/000342405)
Abstract References ORCID License
221.75 164
3 Epidemiology and Surveillance of Hepatocellular Carcinoma (10.1159/000339016)
Abstract References ORCID License
211.73 130
4 Liver Resection and Transplantation in Hepatocellular Carcin… (10.1159/000342403)
Abstract References ORCID License
198.68 96
5 Treatment of Advanced Hepatocellular Carcinoma with Emphasis… (10.1159/000342402)
Abstract References ORCID License
194.45 87
6 Clinical Application of Fluorescence Imaging of Liver Cancer… (10.1159/000339017)
Abstract References ORCID License
187.51 74
7 Local Ablation for Hepatocellular Carcinoma in Taiwan (10.1159/000343843)
Abstract References ORCID License
184.51 69
8 Comparison of International Guidelines for Noninvasive Diagn… (10.1159/000343833)
Abstract References ORCID License
183.88 68
9 Portal Vein Embolization for Hepatocellular Carcinoma (10.1159/000343829)
Abstract References ORCID License
178.53 60
10 Current and Future Treatment Strategies for Patients with Ad… (10.1159/000343839)
Abstract References ORCID License
177.82 59
11 Japan’s Successful Model of Nationwide Hepatocellular Carcin… (10.1159/000342749)
Abstract References ORCID License
177.09 58
12 Early Hepatocellular Carcinoma: Definition and Diagnosis (10.1159/000343842)
Abstract References ORCID License
174.82 55
13 Chemoembolization in Patients with Hepatocellular Carcinoma (10.1159/000339019)
Abstract References ORCID License
174.04 54
14 Delayed Diagnosis of HCC with Chronic Alcoholic Liver Diseas… (10.1159/000343840)
Abstract References ORCID License
173.24 53
15 Recent Advances in CT and MR Imaging for Evaluation of Hepat… (10.1159/000339018)
Abstract References ORCID License
171.60 51
16 Immunotherapeutic Approaches to Hepatocellular Carcinoma Tre… (10.1159/000343837)
Abstract References ORCID License
165.32 44
17 and Functional Significance in the NewClassification of Prim… (10.1159/000343844)
Abstract References ORCID License
159.11 38
18 Application of Radiotherapeutic Strategies in the BCLC-defin… (10.1159/000343836)
Abstract References ORCID License
153.15 33
19 New Paradigm for Management of Hepatocellular Carcinoma by I… (10.1159/000342404)
Abstract References ORCID License
151.85 32
20 Liver Transplantation for Hepatocellular Carcinoma: An Appra… (10.1159/000343832)
Abstract References ORCID License
150.51 31
21 Predictive Biomarkers of Antiangiogenic Therapy for Advanced… (10.1159/000343845)
Abstract References ORCID License
149.14 30
22 Noninvasive Diagnosis of Hepatocellular Carcinoma in Cirrhot… (10.1159/000339020)
Abstract References ORCID License
134.24 21
23 Clinical Impact of Ultrasound-Related Techniques on the Diag… (10.1159/000343838)
Abstract References ORCID License
132.22 20
24 Perspectives on The Design of Clinical Trials Combining Tran… (10.1159/000343830)
Abstract References ORCID License
125.53 17
25 Clinical Practice Guidelines for Hepatocellular Carcinoma Di… (10.1159/000367730)
Abstract References ORCID
123.99 44
26 Are Tumor Exposure and Anatomical Resection Antithetical dur… (10.1159/000343831)
Abstract References ORCID License
120.41 15
27 Combination of Local Transcatheter Arterial Chemoembolizatio… (10.1159/000343835)
Abstract References ORCID License
120.41 15
28 Heterogeneity and Subclassification of Barcelona Clinic Live… (10.1159/000367768)
Abstract References ORCID
110.78 29
29 Association between Loss of Skeletal Muscle Mass and Mortali… (10.1159/000484950)
References ORCID
110.74 163
30 Effectiveness of Sorafenib in Patients with Transcatheter Ar… (10.1159/000367743)
References ORCID
110.48 161
31 Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in… (10.1159/000367760)
Abstract References ORCID
109.68 28
32 Surgical and Locoregional Therapy of HCC: TACE (10.1159/000367739)
References ORCID
108.51 147
33 Tumor Markers for Hepatocellular Carcinoma: Simple and Signi… (10.1159/000367735)
References ORCID
105.70 129
34 Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the… (10.1159/000367754)
References ORCID
105.02 125
35 Patient Selection for Transarterial Chemoembolization in Hep… (10.1159/000485471)
References ORCID
103.96 119
36 Lenvatinib May Drastically Change the Treatment Landscape of… (10.1159/000487148)
Abstract References
103.41 116
37 Regorafenib as Second-Line Systemic Therapy May Change the T… (10.1159/000449335)
Abstract References ORCID
102.13 22
38 Survival Analysis over 28 Years of 173,378 Patients with Hep… (10.1159/000367775)
References ORCID
100.64 102
39 Hepatocellular Carcinoma: Therapeutic Guidelines and Medical… (10.1159/000449343)
References ORCID
100.43 101
40 Recent Progress in the Treatment and Diagnosis of Hepatocell… (10.1159/000346385)
Abstract References ORCID License
100.00 9
41 Current Status of Hepatic Arterial Infusion Chemotherapy (10.1159/000367746)
References ORCID
98.66 93
42 Contrast-Enhanced Ultrasound for the Characterization of Hep… (10.1159/000367738)
References ORCID
97.47 88
43 Molecular Pathogenesis of Hepatocellular Carcinoma (10.1159/000449340)
References ORCID
97.22 87
44 Why Does Every Hepatocellular Carcinoma Clinical Trial Using… (10.1159/000342401)
Abstract References ORCID License
95.42 8
45 Recent Advances in Tumor Ablation for Hepatocellular Carcino… (10.1159/000367740)
References ORCID
95.42 80
46 Colorectal Liver Metastases: A Critical Review of State of t… (10.1159/000449348)
References ORCID
94.88 78
47 Image-Guided Ablation of Malignant Liver Tumors: Recommendat… (10.1159/000367747)
References ORCID
94.60 77
48 The Asia Pacific Consensus Statement on Laparoscopic Liver R… (10.1159/000481834)
References ORCID
94.60 77
49 Prioritized Requirements for First-Line Systemic Therapy for… (10.1159/000528979)
Abstract References ORCID
94.15 17
50 Management of Hepatocellular Carcinoma in Japan as a World-L… (10.1159/000484619)
Abstract References
92.87 71